Evidence map›Paper›PMID 31911575›Full record

ArticleThe American journal of case reports2020

Renal Metastases from a Nasal Cavity Mixed Squamous Cell and Adenoid Cystic Carcinoma: A Case Report.

Raffaele Longo, Camille Jaud, William Gehin, Laurent Hennequin, Claire Bastien, Marco Campitiello, Antonio Rozzi, Francesca Plastino

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Raffaele LongoDivision of Medical Oncology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Camille JaudDivision of Medical Oncology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
William GehinDivision of Medical Oncology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Laurent HennequinDivision of Radiology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Claire BastienDivision of Pathology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Marco CampitielloDivision of Medical Oncology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Antonio RozziDivision of Medical Oncology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Francesca PlastinoDivision of Medical Oncology, "Centre Hospital Regional (CHR) Metz-Thionville", Ars-Laquenexy, France.
Centre Hospitalier Régional de Metz-Thionville · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Adenoid cystic carcinoma (ACC) is a very rare tumor with a high risk of loco-regional recurrence and potential distant metastases. Until now, only a few cases of renal metastases from ACC have been reported in the literature. CASE REPORT A 64-year-old, Caucasian, non-smoker female, 8 months after being treated by radio-chemotherapy for a squamous cell nasal cavity tumor, presented two renal lesions associated with lung and vertebral metastases. Histology was consisted with a metastasis from an ACC. The histological revision of the primary nasal tumor confirmed a squamous cells carcinoma with an adenoid cystic component that metastasized to the kidney. Renal lesions appeared hypometabolic at the ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) PET scan mimicking a primary renal tumor. The patient underwent a systemic, palliative chemotherapy by a weekly carboplatin/paclitaxel/cetuximab regimen that was well tolerated and allowed a lasting tumor control. CONCLUSIONS The particularity of this case relies on the rarity of renal metastasis from ACC, its difficult diagnosis, and the complexity of its management, as no standard chemotherapy has been validated for metastatic ACC, yet. In our case, a weekly carboplatin/paclitaxel/cetuximab regimen was administered leading to a durable tumor stabilization with an excellent patient's quality of life.

Indexed as

CarboplatinCarcinoma, Adenoid CysticCarcinoma, Squamous CellCetuximabDrug Therapy, CombinationFemaleFluorodeoxyglucose F18HumansKidney NeoplasmsMiddle AgedNasal CavityNose NeoplasmsPaclitaxelPalliative CarePositron-Emission TomographyRare DiseasesCarboplatinCetuximabFluorodeoxyglucose F18Paclitaxel

Identifiers

PMID31911575
PMCPMC6977623
OpenAlexW2999280805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.